Wall Street Analysts Update McKesson Price Targets
Multiple major financial institutions have updated their ratings and price targets for McKesson Corporation, with targets now ranging between $1,200 and $1,260.
Stocks · News reference
McKesson Reports Fiscal Q2 2027 Results, Raises Guidance, and Announces Strategic Expansion
McKesson reported strong fiscal Q2 2027 financial results, raised its full-year adjusted EPS guidance, and announced significant new distribution and acquisition agreements.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
McKesson and Clayton, Dubilier & Rice Secure $3.1 Billion Financing for Option Care Health Acquisition
McKesson Corporation and private equity firm Clayton, Dubilier & Rice have engaged Wall Street banks to arrange $3.1 billion in financing to support their acquisition of Option Care Health.
UBS Maintains Buy on McKesson, Raises Price Target to $1250
Evercore ISI Group Raises McKesson Price Target to $1,200
Evercore ISI Group maintained an 'Outperform' rating on McKesson and increased its price target from $1,000 to $1,200.
TD Cowen Maintains Buy on McKesson, Raises Price Target to $1200
RBC Capital Maintains Sector Perform on McKesson, Raises Price Target to $965